All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY1720 | Anti-PTPRB (CBFYH-3641) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-3641 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1721 | Anti-PTPRB (CBFYH-3642) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat | CBFYH-3642 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4973 | Anti-PTPRB (CBFYH-3641) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-3641 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4974 | Anti-PTPRB (CBFYH-3642) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat | CBFYH-3642 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-0320ZP1765 | Anti-PTPRB (R15E6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | R15E6 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1766 | Anti-PTPRB (R15E6) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | R15E6 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1767 | Anti-PTPRB (2-A2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2-A2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1768 | Anti-PTPRB (2-A2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 2-A2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1769 | Anti-PTPRB (122.2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 122.2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1770 | Anti-PTPRB (122.2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 122.2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION